umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
MBNL1 and RBM39 can activate the incorrect splicing of ISCU and the aberrant transcript is a target for nonsense-mediated decay
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Medical and Clinical Genetics. (Monica Holmberg)ORCID iD: 0000-0001-6632-5770
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Medical and Clinical Genetics. (Monica Holmberg)
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Medical and Clinical Genetics. (Monica Holmberg)
(English)Manuscript (preprint) (Other academic)
National Category
Medical Genetics
Identifiers
URN: urn:nbn:se:umu:diva-153148OAI: oai:DiVA.org:umu-153148DiVA, id: diva2:1261603
Available from: 2018-11-08 Created: 2018-11-08 Last updated: 2018-11-09
In thesis
1. The regulation of incorrect splicing of ISCU in hereditary myopathy with lactic acidosis
Open this publication in new window or tab >>The regulation of incorrect splicing of ISCU in hereditary myopathy with lactic acidosis
2018 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Patients suffering from hereditary myopathy with lactic acidosis (HML) can be found in the northern Swedish counties of Ångermanland and Västerbotten. HML is a rare autosomal recessive disease where patients display a low tolerance to exercise at an early age. Exercise can trigger symptoms such as palpitations, tachycardia, muscle cramps and dyspnoea. Extensive exercise or strict diets can result in myoglobinuria and life-threatening levels of lactic acid. The disease is caused by a nonsense G > C mutation (c.418 + 328G < C) in the last intron of the iron-sulphur (FeS) cluster assembly gene (ISCU), resulting in nonsense-mediated decay (NMD) of the transcript due to incorrect splicing. The ISCU protein is involved in the assembly of FeS clusters, which are essential cofactors for a wide range of proteins. Patient muscles display decreased levels of several FeS cluster proteins: mitochondrial aconitase in the tricarboxylic acid (TCA) cycle and Complex I, II (succinate dehydrogenase [SDH]) and III in the electron transport chain (ETC). The incorrect splicing of ISCU occurs to the highest extent in HML patient skeletal muscle, restricting the loss of ISCU protein to muscles, thereby preventing a more severe phenotype.

We found that the incorrect splicing occurs to the highest extent in slow-fibre muscle, which may be caused by the serine/arginine-rich splicing factor (SRSF3) as it is expressed at higher levels in slow-fibre muscle compared to other muscles, and since it is able to activate the incorrect splicing of ISCU. Following muscle, there is a gradual decrease of the incorrect splicing in heart, brain, liver and kidney, which is negatively correlated with the levels of the splicing inhibitor polypyrimidine-tract binding protein 1 (PTBP1). Overexpression of PTBP1 in HML patient myoblasts resulted in a drastic decrease in the incorrect splicing, while a PTBP1 knockdown had the opposite effect. Our results suggest that PTBP1 acts as a dominant inhibitor of the incorrect splicing and is likely the main cause for the tissue-specific splicing of ISCU in HML. We also identified RBM39 and MBNL1 as activators of the incorrect splicing of ISCU, which, together with the low levels of PTBP1, could explain the high levels of incorrect splicing in muscle.

Since almost 95% of all human gene transcripts are alternatively spliced, it is not surprising that a wide range of diseases are caused by mutations that affect splicing. Further knowledge of the function of splicing, such as tissue-specific splicing, can provide vital information for the development of therapies for diseases caused by splicing.

Place, publisher, year, edition, pages
Umeå: Umeå Universitet, 2018. p. 68
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 1978
Keywords
HML, ISCU, Splicing, SRSF3, PTBP1, RBM39, MBNL1
National Category
Medical Genetics
Research subject
Medical Genetics
Identifiers
urn:nbn:se:umu:diva-153174 (URN)978-91-7601-954-2 (ISBN)
Public defence
2018-12-04, Betula, Byggnad 6M, Umeå, 09:00 (English)
Opponent
Supervisors
Available from: 2018-11-13 Created: 2018-11-08 Last updated: 2018-11-09Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records BETA

Rawcliffe, Denise F. R.Österman, LennartHolmberg, Monica

Search in DiVA

By author/editor
Rawcliffe, Denise F. R.Österman, LennartHolmberg, Monica
By organisation
Medical and Clinical Genetics
Medical Genetics

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 60 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf